{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T13:15:34Z","timestamp":1662383734245},"reference-count":38,"publisher":"Informa UK Limited","issue":"7","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2022,7,3]]},"DOI":"10.1080\/17512433.2022.2103537","type":"journal-article","created":{"date-parts":[[2022,7,16]],"date-time":"2022-07-16T09:56:30Z","timestamp":1657965390000},"page":"799-803","update-policy":"http:\/\/dx.doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":0,"title":["Dasiglucagon for treating severe hypoglycemia in patients with diabetes"],"prefix":"10.1080","volume":"15","author":[{"given":"Yongjing","family":"Ju","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical, Central Hospital of Linyi City, Yishui, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duzhen","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department Ophthalmology, Central Hospital of Linyi City, Yishui, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junyi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical, Central Hospital of Linyi City, Yishui, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2022,7,24]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(18)30315-2"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2480"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1007\/5584_2020_534"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S129268"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2016.19975"},{"key":"cit0006","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1310"},{"key":"cit0007","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1215228"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.7573\/dic.212599"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.2147\/DMSO.S20633"},{"key":"cit0010","doi-asserted-by":"publisher","DOI":"10.1177\/193229681000400609"},{"key":"cit0011","unstructured":"U.S. Food and Drug Administration. ZEGALOGUE (dasiglucagon) injection, for subcutaneous use. cited 2021 Apr 15. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2021\/214231s000lbl.pdf"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.12698"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-008-7479-6"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1177\/193229681000400606"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2011.08465.x"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1177\/1932296814555541"},{"key":"cit0017","unstructured":"U.S. Food and Drug Administration. BAQSIMI (glucagon) nasal powder. cited 2021 Jul 24. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/210134s000lbl.pdf"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-1498"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13581"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1177\/193229681000400607"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-016-4107-0"},{"key":"cit0022","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2018.0363"},{"key":"cit0023","unstructured":"U.S. Food and Drug Administration. Clinical pharmacology review(s). cited April 15. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2021\/214231Orig1s000ClinPharmR.pdf"},{"key":"cit0024","unstructured":"U.S. Food and Drug Administration. Non-clinical review(s). cited 2021 Jul 24. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2021\/214231Orig1s000PharmR.pdf"},{"key":"cit0025","doi-asserted-by":"publisher","DOI":"10.1080\/14656566.2020.1747432"},{"key":"cit0026","doi-asserted-by":"publisher","DOI":"10.2337\/dc17-1402"},{"key":"cit0027","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13562"},{"key":"cit0028","unstructured":"U.S. Food and Drug Administration. Clinical review(s); 2021. cited 2021 Apr 15. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2021\/214231Orig1s000MedR.pdf."},{"key":"cit0029","unstructured":"ClinicalTrials.gov.trial to confirm the clinical efficacy and safety of dasiglucagon in the treatment of hypoglycemia in subjects with T1DM. cited 2021 Apr 15. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT03688711?term=NCT03688711&draw=2&rank=1"},{"key":"cit0030","doi-asserted-by":"publisher","DOI":"10.2337\/DC20-2995"},{"key":"cit0031","doi-asserted-by":"publisher","DOI":"10.1111\/pedi.13220"},{"key":"cit0032","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-S006"},{"key":"cit0033","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2016.06.004"},{"key":"cit0034","doi-asserted-by":"publisher","DOI":"10.4274\/jcrpe.1891"},{"key":"cit0035","doi-asserted-by":"publisher","DOI":"10.1002\/pdi.138"},{"key":"cit0036","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133314"},{"key":"cit0037","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20215407"},{"key":"cit0038","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-019-1216-4"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2022.2103537","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,5]],"date-time":"2022-09-05T12:28:42Z","timestamp":1662380922000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2022.2103537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,3]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,3]]}},"alternative-id":["10.1080\/17512433.2022.2103537"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2022.2103537","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,3]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2022-07-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}